drugset / Trial / NCT06550362

Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA

NCT06550362

Phase 4 Not yet recruiting 100 enrolled Loma Linda University
RandomizedParallel-groupOpen-labelTreatment

Summary

Iron Deficiency Anemia (IDA) is a prevalent global health issue affecting a significant proportion of the population, including children. While daily oral iron supplementation is a common approach to treat IDA, concerns regarding side effects and compliance have led to exploration of alternative dosing schedules, such as every-other-day. This study aims to investigate the efficacy and safety of daily versus every other day oral iron supplementation in the management of IDA in pediatric patients.

Timeline

Start
2026-12
Primary completion
2027-05
Completion
2027-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron Sulfate Small molecule 6 mg/kg Oral